Try our beta test site
1 study found for:    19789316 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma
Condition: Large Cell Lymphoma
Intervention: Drug: SGN-30

Study has passed its completion date and status has not been verified in more than two years.